Benzinga | Jan 14, 2022 06:37AM EST

HC Wainwright & Co. Maintains Buy on ProPhase Labs, Raises Price Target to $15

HC Wainwright & Co. analyst Yi Chen maintains ProPhase Labs (NASDAQ:PRPH) with a Buy and raises the price target from $12 to $15.